Global Reproductive Health Leader Target opportunities in IVF clinics and reproductive health centers leveraging Vitrolife's global leadership and integrated offerings from devices to genetic testing services, including potential upsell of end-to-end solutions.

Acquisition Synergy Leverage the Igenomix acquisition to position cross-sell between genetic testing services and Vitrolife’s medical devices, offering bundled solutions to clinics seeking comprehensive reproductive-health workflows.

Expansion Footprint Focus sales efforts on countries where Vitrolife operates directly (over 25 countries) and in high-potential markets reachable via distributors, emphasizing training, support, and guaranteed quality to secure new clinic partnerships.

Executive Leadership Monitor leadership changes and align outreach with new executives (CEO and COO appointments) to time strategic conversations around product roadmaps, operational efficiency, and expansion initiatives.

Strategic Partnerships Identify opportunities from existing partnerships (e.g., GE Healthcare ultrasound optimization) to propose integrated solutions that enhance procedural visibility, precision, and patient outcomes in fertility treatments.